Derby: New anti-viral drug study aims to cure long Covid
Long Covid symptoms include extreme fatigue and breathlessness, palpitations, or brain fog. Source link
antiviral
Molnupiravir Covid antiviral treatment hastens recovery – trial
Former deputy chief medical officer for England, Prof Sir Jonathan Van-Tam, who is pro-vice-chancellor for the Faculty of Medicine and Health Sciences at the University of Nottingham and study co-author, said: “While molnupiravir was originally found to work well to reduce hospitalisation in patients with Covid, these were unvaccinated patients. Source link
Monkeypox antiviral drug put to the test in trial
Tecovirimat – also known as Tpoxx – prevents the virus from leaving infected cells, stopping its spread within the body. It was licensed earlier this year for monkeypox, based on promising results from initial studies in animals and evidence of safety in healthy human volunteers. Source link
Effectiveness of Antiviral Drugs Against Monkeypox Uncertain
By Ernie Mundell HealthDay Reporter WEDNESDAY, May 25, 2022 (HealthDay News) — Up until recently monkeypox infection outside of Africa was rare, but a look back at seven cases occurring in Britain over the past few years gives hints at what drugs work to fight the disease — and which don’t. The need to better … Read more
Thousands needed to try a new Covid antiviral treatment
A UK study aims to find out who will benefit most from a pill designed to treat Covid-19. Source link
Paxlovid: UK medicines regulator approves second Covid antiviral pill
Paxlovid can cut the risk of hospitalisation in vulnerable adults by 89%, a clinical trial suggests. Source link
The New COVID Antiviral Pills: What You Need to Know
By Dennis Thompson HealthDay Reporter WEDNESDAY, Dec. 29, 2021 (HealthDay News) — New antiviral pills for COVID-19 recently authorized for emergency use in high-risk people by the U.S. Food and Drug Administration should give doctors an easier means of keeping people out of the hospital. But the initial hype is … Read more
FDA Authorizes Pfizer Antiviral Pill for COVID-19
Dec. 22, 2021 – The FDA on Wednesday granted emergency use authorization of a new antiviral pills to treat people with symptomatic COVID-19. Pfizer’s ritonavir, name brand Paxlovid, can now be taken by patients age 12 and up who weigh at least 88 pounds. The antiviral is only for people who test positive for coronavirus, … Read more
Merck’s COVID-19 Pill May Be Less Effective Than First Hoped
Nov. 29, 2021 — Merck’s antiviral pill for COVID-19, molnupiravir, appears to be far less effective than early results from the clinical trial first suggested. According to an analysis by scientists at the FDA, the experimental pill cut the risk of hospitalization or death from COVID-19 by about 30%, compared to a placebo, and the … Read more
Covid: Pfizer says antiviral pill 89% effective in high risk cases
The company stopped clinical trials early because initial results for the drug were so positive. Source link